4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-004645
Options or other derivatives
- SVP, Chief Financial Officer acquired 40,796 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sun Elaine D · SVP, Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-01 | Grant or award : show line 1 in the form Performance Stock Units | +40,796 | $0.00 | 40,796 | 40,796 | D |
Loading xslF345X03/edgar.xml…